Biolife Solutions (BLFS) Receivables (2010 - 2026)

Biolife Solutions (BLFS) has reported Receivables for 17 consecutive years, with $10.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables rose 5.88% year-over-year to $10.7 million in Q2 2026; TTM through Jun 2026 was $10.7 million, a 5.88% increase from a year earlier, with the FY2025 full-year figure at $8.0 million, down 6.17% from the prior year.
• Receivables was $10.7 million for Q2 2026 at Biolife Solutions, down from $13.1 million in the prior quarter.
• Over five years, Receivables peaked at $33.9 million in Q4 2022 and troughed at $7.9 million in Q4 2023.
• A 5-year average of $18.7 million and a median of $18.0 million in 2024 frame the typical range for Receivables.
• Across the five-year window, Receivables jumped 127.49% in 2022 and slumped 76.73% in 2023, its largest moves.
• Over 5 years, Receivables stood at $33.9 million in 2022, then tumbled by 76.73% to $7.9 million in 2023, then climbed by 7.32% to $8.5 million in 2024, then decreased by 6.17% to $8.0 million in 2025, then soared by 33.94% to $10.7 million in 2026.
• The last three Receivables figures came in at $10.7 million (Q2 2026), $13.1 million (Q1 2026), and $8.0 million (Q4 2025), per Business Quant data.